UPDATE : Wednesday, July 17, 2019
상단여백
SNUH closer to developing cell-gene therapy to regenerate heart muscle
Researchers at Seoul National University Hospital have found evidence to de...
by Lee Han-soo  |  2019-07-04 15:33
라인
Kolon confident to resume US trial on Invossa
The government has decided to nullify Invossa-K’s license effective next Tu...
by Lee Hye-seon  |  2019-07-04 14:05
라인
China OKs Alteogen’s Herceptin biosimilar for clinical trials
Alteogen said that Qilu Pharmaceutical, its Chinese partner, has received i...
by Lee Han-soo  |  2019-07-04 14:04
라인
‘Truvada will improve Korea's HIV treatment environment’
Gilead Science is strengthening its position in the local human immunodefic...
by Lee Han-soo  |  2019-07-04 10:53
라인
Janssen nixes deal with Hanmi over antidiabetic obesity drug
Janssen, a subsidiary of Johnson & Johnson, has decided to return the devel...
by Jeong Sae-im  |  2019-07-04 10:52
라인
Rheumatoid arthritis treatment can improve Alzheimer symptoms
A local research has found that Humira, Abbvie's rheumatoid arthritis d...
by Lee Han-soo  |  2019-07-03 18:01
라인
‘Psoriasis patients have redoubled risk of suffering from mental illness’
A research team at St. Mary’s hospital has found that patients who have pso...
by Lee Han-soo  |  2019-07-03 16:18
라인
‘State lung cancer screening will raise false positive diagnoses’
The government has decided to add lung cancer to the state cancer screening...
by Kim Eun-young  |  2019-07-03 15:38
라인
Bukwang, UK university to co-develop Parkinson’s disease treatment
Bukwang Pharmaceutical has signed a multibillion-won contract with Universi...
by Lee Han-soo  |  2019-07-03 15:03
라인
Myongji Hospital celebrates 10 years of innovation and change
Myongji Hospital has done all it could to change and innovate the hospital’...
by Lee Han-soo  |  2019-07-03 13:31
라인
Regulator revokes Invossa license; Kolon CEO ‘to fight in court’
Kolon Life Science CEO said he would seek an administrative suit against th...
by Lee Hye-seon  |  2019-07-03 11:52
라인
SNUH will continue to operate Sheikh Khalifa Special Hospital
Seoul National University Hospital (SNUH) said it has won the renewal of th...
by Lee Han-soo  |  2019-07-02 17:07
라인
‘Patients with myeloproliferative neoplasm unaware of cause before diagnosis’
Most patients with a myeloproliferative neoplasm (MPN) were unaware of the ...
by Kim Yun-mi  |  2019-07-02 16:42
라인
Handok releases Fabry disease treatment
Handok said Tuesday that it has rolled out Galafold, a Fabry disease treatm...
by Lee Han-soo  |  2019-07-02 16:19
라인
'Pituitary tumor can impair eyesight'
A research team at Kyung Hee University Hospital at Gangdong has discovered...
by Lee Han-soo  |  2019-07-02 15:28
라인
26 new drugs approved in H1
Twenty-six new pharmaceutical products received approval in Korea in the fi...
by Lee Hye-seon  |  2019-07-02 14:31
라인
Korean, US national cancer centers co-research proteogenomics
The National Cancer Center (NCC) has signed a memorandum of understanding w...
by Lee Han-soo  |  2019-07-02 12:11
라인
[News Focus]Yuhan pulled off $3.1 billion licensing deals in one year. How?
Yuhan Corp. recently made headlines by signing an $870 million licensing de...
by Jeong Sae-im  |  2019-07-02 12:11
라인
Regulator OKs nation’s 1st clinical trial for ‘digital treatment’
The Ministry of Food and Drug Safety has approved Nunaps’ clinical trial of...
by Lee Han-soo  |  2019-07-01 16:35
라인
[Special]Korean drugmakers harbor undue expectations on global blockbusters
“The pharmaceutical and biotech industry will lead our economy soon. Even n...
by Jeong Sae-im  |  2019-07-01 16:19
여백
여백
여백
Back to Top